Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;100(6):1086-1121.
doi: 10.1111/cbdd.14100. Epub 2022 Jun 27.

1,3,4-oxadiazole derivatives as potential antimicrobial agents

Affiliations
Review

1,3,4-oxadiazole derivatives as potential antimicrobial agents

Deeksha Tiwari et al. Chem Biol Drug Des. 2022 Dec.

Abstract

Due to the emergence of drug-resistant microbial strains, different research groups are continuously developing novel drug molecules against already exploited and unexploited targets. 1,3,4-Oxadiazole derivatives exhibited noteworthy antimicrobial activities. The presence of 1,3,4-oxadiazole moiety in antimicrobial agents can modify their polarity and flexibility, which significantly improves biological activities due to various bonded and non-bonded interactions viz. hydrogen bond, steric, electrostatic, and hydrophobic with target sites. The present review elaborates the therapeutic targets and mode of interaction of 1,3,4-oxadiazoles as antimicrobial agents. 1,3,4-oxadiazole derivatives target enoyl reductase (InhA), 14α-demethylase in the mycobacterial cell; GlcN-6-P synthase, thymidylate synthase, peptide deformylase, RNA polymerase, dehydrosqualene synthase in bacterial strains; ergosterol biosynthesis pathway, P450-14α demethylase, protein-N-myristoyltransferase in fungal strains; FtsZ protein, interfere with purine and functional protein synthesis in plant bacteria. The present review also summarizes the effect of different moieties and functional groups on the antimicrobial activity of 1,3,4-oxadiazole derivatives.

Keywords: 1,3,4-Oxadiazole derivatives; 3D-QSAR; antimicrobial; molecular docking; structure-activity relationship; therapeutic targets.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Ahsan, M. J., Samy, J. G., Khalilullah, H., Nomani, M. S., Saraswat, P., Gaur, R., & Singh, A. (2011). Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents. Bioorganic and Medicinal Chemistry Letters, 21(24), 7246-7250. https://doi.org/10.1016/j.bmcl.2011.10.057
    1. Akhtar, T., Khan, M. A., Iqbal, J., Jones, P. G., & Hameed, S. (2014). A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies. Chemical Biology and Drug Design, 84(1), 92-98. https://doi.org/10.1111/cbdd.12297
    1. Alrazzak, N. A. (2018). Synthesis, characterization and study some of physical properties of novel 1,3,4-oxadiazole derivatives. IOP Conference Series: Materials Science and Engineering, 454, 012096. https://doi.org/10.1088/1757-899X/454/1/012096
    1. Ambhore, A. N., Kamble, S. S., Kadam, S. N., Kamble, R. D., Hebade, M. J., Hese, S. V., Gaikwad, M. V., Meshram, R. J., Gacche, R. N., & Dawane, B. S. (2019). Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent. Computational Biology and Chemistry, 80, 54-65. https://doi.org/10.1016/j.compbiolchem.2019.03.002
    1. Asgaonkar, K. D., Mote, G. D., & Chitre, T. S. (2014). QSAR and molecular docking studies of oxadiazole-ligated pyrrole derivatives as enoyl-ACP (CoA) reductase inhibitors. Scientia Pharmaceutica, 82(1), 71-85. https://doi.org/10.3797/scipharm.1310-05

MeSH terms

LinkOut - more resources